4
Changes in Ownership
NewAmsterdam Pharma Co N.V. Filed Acc 0000950170-25-010594
Chief Financial Officer sold 61,883 shares
- Chief Financial Officer acquired 61,883 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Somaiya Mayur Ian · Chief Financial Officer
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-01-27 | Exercise or conversion : show line 1 in the form 10b5-1 | +46,983 | $9.26 | $435,063 | 84,983 | D |
| 2025-01-27 | Sale : show line 2 in the form 10b5-1 | −33,679 | 51,304 | D | ||
| 2025-01-27 | Sale : show line 3 in the form 10b5-1 | −13,304 | 38,000 | D | ||
| 2025-01-28 | Exercise or conversion : show line 4 in the form 10b5-1 | +14,900 | $9.26 | $137,974 | 52,900 | D |
| 2025-01-28 | Sale : show line 5 in the form 10b5-1 | −11,495 | 41,405 | D | ||
| 2025-01-28 | Sale : show line 6 in the form 10b5-1 | −3,405 | 38,000 | D | ||
| Open-market sales · 61,883 sh | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-01-27 | Exercise or conversion : show line 7 in the form 10b5-1 Option (Right to Buy) | −46,983 | 777,714 | D |
| 2025-01-28 | Exercise or conversion : show line 8 in the form 10b5-1 Option (Right to Buy) | −14,900 | 762,814 | D |
Loading xslF345X05/ownership.xml…